This inventor holds 1 USPTO granted patent. Top assignee: Hummingbird Diagnostics Gmbh. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Matthias Hubenthal: Innovator in Diagnostic Methods for Inflammatory Bowel Disease
Introduction
Matthias Hubenthal is a prominent inventor based in Kiel, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of inflammatory bowel disease (IBD). His innovative approach focuses on the use of microRNAs (miRNAs) as non-invasive biomarkers for diagnosing IBD.
Latest Patents
Matthias Hubenthal holds a patent for his invention titled "MiRNAs as non-invasive biomarkers for inflammatory bowel disease." This patent outlines a method for diagnosing IBD by determining expression profiles of miRNAs that are representative of the disease compared to a reference. Additionally, the invention includes a kit designed for the diagnosis of IBD, which comprises means for determining these expression profiles.
Career Highlights
Hubenthal is associated with Hummingbird Diagnostics GmbH, where he continues to advance research in diagnostic methods. His work has been instrumental in developing non-invasive techniques that can improve patient outcomes in the diagnosis of IBD.
Collaborations
Some of his notable coworkers include Thomas Brefort and Andre Franke, who contribute to the collaborative efforts at Hummingbird Diagnostics GmbH.
Conclusion
Matthias Hubenthal's innovative work in the field of diagnostics exemplifies the potential of using miRNAs as biomarkers for inflammatory bowel disease. His contributions are paving the way for more effective and non-invasive diagnostic methods in medicine.